Employer record no. 23435
Envision Pharma, Inc.
US DOL LCA disclosure data, FY2020 to FY2024
Total LCA filings
12
Certified
9
Denied
0
FY2024 filings
3
Filings by fiscal year
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 4 | 2 | 0 | $75,000 | $65,811 |
| FY2021 | 3 | 2 | 0 | $148,419 | $133,536 |
| FY2022 | 1 | 1 | 0 | $100,500 | $100,360 |
| FY2023 | 1 | 1 | 0 | $73,000 | $62,982 |
| FY2024 | 3 | 3 | 0 | $126,293 | $118,699 |
What they file for
- medical writer$74,6005
- senior scientific director & team lead$148,4193
- manager, strategic consulting$160,0001
- senior medical writer$101,6701
- software developer ii$100,5001
- software developer iii$117,2081
Where
- philadelphia, pa3
- warren, nj3
- chicago, il1
- fairfield, ct1
- glastonbury, ct1
- newington, ct1
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Envision Pharma, Inc. and any other employer they watch.
Certification rate 75.0%How these numbers are computed